S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
FLGT · Fulgent Genetics, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Fulgent Genetics Inc (FLGT)
NASDAQ NMS - GLOBAL MARKET
Health Care
$20.14
-0.18
(-0.89%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$20.14
$20.04
$20.36
52-WEEK RANGE
$20.14
$13.46
$31.04
What's happening
- FLGT is down 0.89% today, trading at $20.14. — Live quote
- Volume today (11,823) is well below its 3-month average of 294,130. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (before market open), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.58 actual vs. $-0.47 estimated (-23.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 1
Strong sell 2
Aggregate ratings for 2026-10-01 (6 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
FLGT
-23.37%
vs S&P 500
-36.74%
1-YEAR RETURN
FLGT
-16.02%
vs S&P 500
-31.18%
6-MONTH RETURN
FLGT
+23.80%
3-MONTH RETURN
FLGT
+3.07%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.58
Est. $-0.47
MISS -23.6%
2026-04-26 (Q1 2026)
$-0.36
Est. $-0.11
MISS -236.1%
2026-01-26 (Q4 2025)
$-0.36
Est. $-0.11
MISS -236.1%
2025-10-26 (Q3 2025)
$0.14
Est. $-0.23
BEAT +161.5%
Valuation Measures & Ratios
Enterprise Value4$533.0M
Forward P/E5—
PEG Ratio6-0.10
Price / Sales (TTM1)1.71
Price / Book70.58
EV4 / Revenue1.65
EV4 / EBITDA2.88
Profit Margin-26.05%
Operating Margin-37.75%
Return on Equity (ROE8)-7.87%
Return on Assets (ROA9)-7.22%
Avg Volume (3M)294,130
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,238,210
Change from Prior Settlement-3.44%
% of Float—
Days to Cover (Short Ratio)7.18
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 4.4% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-03; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -26.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -16.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on FLGT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85.4M | $71.1M | $84.1M | $81.8M | $73.5M | $71.7M | $71.0M | $64.5M |
| Gross profit | $25.7M | $21.5M | $35.5M | $34.4M | $28.3M | $26.8M | $26.5M | $22.1M |
| Operating income | -$36.1M | -$34.6M | -$15.3M | -$19.7M | -$19.8M | -$17.1M | -$18.9M | -$21.8M |
| Net income | -$29.5M | -$24.8M | -$6.6M | -$19.0M | -$11.5M | -$14.6M | -$8.7M | -$13.5M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| EPS (basic) | — | — | — | — | — | — | — | — |
| Operating margin | -$42 | -$49 | -$18 | -$24 | -$27 | -$24 | -$27 | -$34 |
| Net margin | -$35 | -$35 | -$8 | -$23 | -$16 | -$20 | -$12 | -$21 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.09B | $1.16B | $1.21B | $1.21B | $1.20B | $1.21B | $1.22B | $1.23B |
| Total liabilities | $93.2M | $112.2M | $106.8M | $93.8M | $88.2M | $83.0M | $90.8M | $98.9M |
| Stockholders' equity | $1.00B | $1.05B | $1.11B | $1.13B | $1.12B | $1.13B | $1.13B | $1.14B |
| Total current assets | $454.8M | $479.0M | $550.5M | $507.4M | $428.7M | $416.8M | $353.6M | $326.5M |
| Total current liabilities | $71.8M | $90.1M | $85.0M | $72.4M | $71.3M | $65.9M | $72.9M | $74.0M |
| Cash & equivalents | $26.3M | $23.4M | $50.2M | $117.6M | $87.9M | $67.3M | $55.1M | $58.0M |
| Accounts receivable | $64.9M | $69.3M | $84.8M | $71.2M | $77.2M | $71.5M | $69.0M | $57.3M |
| Inventory | $793.0K | $770.0K | — | — | — | — | — | — |
| Other current assets | $22.2M | $24.3M | $22.6M | $60.4M | $58.6M | $25.0M | $23.0M | $56.2M |
| Property, plant & equipment | $113.1M | $116.3M | $112.5M | $111.9M | $110.2M | $107.1M | $105.5M | $106.8M |
| Goodwill | $53.9M | $53.7M | $25.1M | $25.1M | $22.1M | $22.1M | $22.1M | $22.1M |
| Intangible assets | $149.3M | $154.0M | $133.3M | $135.3M | $135.3M | $133.0M | $135.0M | $137.1M |
| Other non-current assets | $23.9M | $25.0M | $22.9M | $23.2M | $23.3M | $32.7M | $33.5M | $39.0M |
| Accounts payable | $15.6M | $21.1M | $18.7M | $18.1M | $18.9M | $18.2M | $18.4M | $19.8M |
| Accrued liabilities | $23.5M | $34.9M | $34.1M | $23.0M | $21.7M | $16.7M | $24.3M | $23.9M |
| Deferred revenue (current) | $3.4M | $3.0M | $3.6M | $2.3M | $2.7M | $2.8M | $2.2M | $3.0M |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $9.0M | $9.4M | $7.6M | $7.6M | $5.9M | $6.1M | $7.0M | $11.8M |
| Common stock & paid-in capital | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained earnings | $475.6M | $505.1M | $530.0M | $553.4M | $560.0M | $578.9M | $590.5M | $596.4M |
| Accumulated other comprehensive income (loss) | $1.9M | $4.5M | $7.5M | $6.8M | $6.0M | $4.3M | -$368.0K | $9.2M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$23.8M | $7.1M | -$78.1M | $11.1M | -$30.2M | -$4.4M | $25.0M | -$15.5M |
| Investing cash flow | $50.8M | $10.9M | $11.2M | $19.1M | $53.4M | $27.7M | -$27.5M | $9.0M |
| Financing cash flow | -$24.2M | -$44.8M | -$534.0K | -$445.0K | -$2.6M | -$11.2M | -$327.0K | -$567.0K |
| Free cash flow | -$27.6M | $1.9M | -$83.1M | $5.1M | -$37.0M | -$9.1M | $21.2M | -$35.0M |
| Capital expenditures | $3.9M | $5.2M | $5.0M | $6.0M | $6.8M | $4.7M | $3.8M | $19.5M |
| Depreciation & amortization | $7.7M | $6.0M | $6.1M | $6.0M | $6.1M | $5.9M | $6.2M | $5.9M |
| Share-based compensation | $8.6M | $9.9M | $9.3M | $9.7M | $10.0M | $10.6M | $10.4M | $10.9M |
| Deferred income taxes | -$90.0K | -$1.1M | -$104.0K | -$864.0K | -$113.0K | -$133.0K | -$364.0K | -$2.4M |
| Change in accounts receivable | -$729.0K | -$16.4M | $15.4M | -$4.9M | $8.3M | $4.5M | $13.3M | $1.6M |
| Change in accounts payable | -$3.4M | -$408.0K | $924.0K | -$102.0K | $386.0K | -$658.0K | -$808.0K | $2.3M |
| Purchases of investments | $0 | $10.0M | $62.0M | $18.9M | $0 | $0 | $98.2M | $115.4M |
| Sales/maturities of investments | $33.1M | $0 | $0 | $0 | $0 | $0 | $47.4M | $25.9M |
| Share repurchases | $23.8M | $40.1M | $0 | $0 | $2.2M | $8.7M | $0 | $0 |
| Tax withholding on stock comp | $334.0K | $4.2M | $447.0K | $357.0K | $345.0K | $1.9M | $242.0K | $431.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $322.7M | $283.5M | $289.2M | $619.0M | $992.6M |
| Gross profit | $130.9M | $107.2M | $104.5M | $366.9M | $777.1M |
| Operating income | -$91.1M | -$73.9M | -$195.5M | $178.5M | $676.0M |
| Net income | -$60.5M | -$42.7M | -$167.8M | $143.4M | $507.4M |
| Operating margin | -$28 | -$26 | -$68 | $29 | $68 |
| Net margin | -$19 | -$15 | -$58 | $23 | $51 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.21B | $1.22B | $1.24B | $1.39B | $1.28B |
| Total liabilities | $106.8M | $90.8M | $102.0M | $116.2M | $112.8M |
| Stockholders' equity | $1.11B | $1.13B | $1.14B | $1.27B | $1.16B |
| Total current assets | $550.5M | $353.6M | $507.8M | $627.9M | $612.0M |
| Total current liabilities | $85.0M | $72.9M | $73.0M | $88.1M | $105.3M |
| Cash & equivalents | $50.2M | $55.1M | $97.5M | $79.5M | $164.9M |
| Accounts receivable | $84.8M | $69.0M | $51.1M | $52.7M | $138.9M |
| Other current assets | $22.6M | $23.0M | $32.6M | $48.9M | $22.5M |
| Property, plant & equipment | $112.5M | $105.5M | $83.5M | $81.4M | $62.3M |
| Goodwill | $25.1M | $22.1M | $22.1M | $143.0M | $50.9M |
| Intangible assets | $133.3M | $135.0M | $143.1M | $150.6M | $35.9M |
| Other non-current assets | $22.9M | $33.5M | $34.9M | $44.1M | $10.7M |
| Accounts payable | $18.7M | $18.4M | $15.4M | $23.1M | $20.5M |
| Accrued liabilities | $34.1M | $24.3M | $30.7M | $25.0M | $17.7M |
| Deferred revenue (current) | $3.6M | $2.2M | $2.9M | $3.2M | $14.6M |
| Other current liabilities | — | — | $164.0K | $5.3M | $680.0K |
| Other non-current liabilities | $7.6M | $7.0M | $15.1M | $18.2M | $6.8M |
| Common stock & paid-in capital | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained earnings | $530.0M | $590.5M | $633.2M | $801.0M | $657.6M |
| Accumulated other comprehensive income (loss) | $7.5M | -$368.0K | $1.2M | -$20.9M | -$759.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$101.6M | $21.1M | $27.0M | $253.5M | $538.6M |
| Investing cash flow | $111.4M | -$58.4M | $38.9M | -$261.3M | -$546.5M |
| Financing cash flow | -$14.8M | -$4.8M | -$47.8M | -$77.1M | $85.4M |
| Free cash flow | -$124.2M | -$19.3M | $4.8M | $234.7M | $514.8M |
| Capital expenditures | $22.6M | $40.3M | $22.2M | $18.8M | $23.8M |
| Depreciation & amortization | $24.1M | $24.9M | $26.1M | $32.7M | $11.0M |
| Share-based compensation | $39.6M | $44.5M | $42.9M | $32.6M | $15.9M |
| Deferred income taxes | -$1.2M | -$3.7M | $11.5M | -$8.3M | -$8.2M |
| Change in accounts receivable | $23.3M | $16.3M | -$2.4M | -$68.6M | -$42.3M |
| Change in accounts payable | $550.0K | $3.1M | -$6.9M | -$25.3M | -$12.2M |
| Purchases of investments | $80.8M | $472.4M | $491.9M | $418.0M | $710.5M |
| Sales/maturities of investments | $0 | $104.3M | $44.1M | $140.2M | — |
| Share repurchases | $10.9M | $225.0K | $25.1M | $74.3M | — |
| Tax withholding on stock comp | $3.0M | $2.9M | $2.7M | $1.8M | $4.2M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding FLGT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers47.5%
Shares Outstanding28,005,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,286,669 | $46.9M | 8.17% | -17.6% | 2026-08-07 |
| ACADIAN ASSET MANAGEMENT LLC | 1,017,913 | $20.9K | 3.63% | -17.5% | 2026-08-12 |
| VANGUARD CAPITAL MANAGEMENT LLC | 789,498 | $16.2M | 2.82% | -10.3% | 2026-06-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 782,116 | $16.0M | 2.79% | +119.5% | 2026-08-12 |
| Jpmorgan Chase & Co | 756,558 | $15.5M | 2.70% | +64.3% | 2026-08-12 |
| Diametric Capital, LP | 697,784 | $14.3M | 2.49% | +93.3% | 2026-08-14 |
| Ameriprise Financial Inc | 670,084 | $13.8M | 2.39% | +18.9% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 625,355 | $12.8M | 2.23% | -6.9% | 2026-08-11 |
| GEODE CAPITAL MANAGEMENT, LLC | 521,014 | $10.7M | 1.86% | -10.8% | 2026-08-12 |
| State Street Corp | 498,673 | $10.2M | 1.78% | -5.8% | 2026-08-07 |
| Invenomic Capital Management LP | 498,287 | $10.2M | 1.78% | -18.4% | 2026-08-14 |
| TWO SIGMA INVESTMENTS, LP | 400,986 | $8.2M | 1.43% | +24.5% | 2026-08-07 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 350,987 | $7.2M | 1.25% | -0.9% | 2026-08-14 |
| MILLENNIUM MANAGEMENT LLC | 320,910 | $6.6M | 1.15% | -20.1% | 2026-08-14 |
| Goldman Sachs Group Inc | 307,940 | $6.3M | 1.10% | -1.1% | 2026-08-14 |
| D. E. Shaw & Co., Inc. | 292,006 | $6.0M | 1.04% | -40.0% | 2026-08-14 |
| HRT FINANCIAL LP | 229,444 | $4.7K | 0.82% | +394.0% | 2026-08-14 |
| Peapod Lane Capital LLC | 224,207 | $4.6M | 0.80% | +1.6% | 2026-07-27 |
| Point72 Asset Management, L.P. | 211,708 | $4.3M | 0.76% | +0.0% | 2026-08-14 |
| Medina Value Partners, LLC | 193,061 | $4.0M | 0.69% | +13.5% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 186,311 | $3.8M | 0.67% | -13.7% | 2026-06-30 |
| Bank Of America Corp /De/ | 175,581 | $3.6M | 0.63% | +45.6% | 2026-08-14 |
| UBS Group AG | 174,952 | $3.6M | 0.62% | -27.3% | 2026-08-13 |
| CITADEL ADVISORS LLC | 174,180 | $3.6M | 0.62% | +229.0% | 2026-08-14 |
| Northern Trust Corp | 170,018 | $3.5M | 0.61% | -6.6% | 2026-08-12 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-26 to 2026-09-02
Recent transactions
- Insiders have net sold 11,912 shares over the last 182 days, across 0 purchases and 8 sales.
- Most recent: Gao Hanlin (Chief Scientific Officer) — Open market sale of 1,673 shares on 2026-09-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)11,912 sh(8 txns)
Net Shares-11,912
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer | Open market sale | 2026-09-02 | 1,673 |
| Xie Jian | President and COO | Open market sale | 2026-09-02 | 2,127 |
| Kim Paul | CFO and Treasurer | Tax withholding | 2026-09-01 | 2,087 |
| Hsieh Ming | Chief Executive Officer | Tax withholding | 2026-09-01 | 4,392 |
| Nohaile Michael | Reporting person | Grant / award | 2026-05-14 | 5,558 |
| Dong Linda | Reporting person | Grant / award | 2026-05-14 | 11,117 |
| GROVES REGINA E | Reporting person | Grant / award | 2026-05-14 | 11,117 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | Gao Hanlin | Chief Scientific Officer | Open market sale | 1,673 | $19.66 |
| 2026-09-02 | Xie Jian | President and COO | Open market sale | 2,127 | $19.66 |
| 2026-09-01 | Kim Paul | CFO and Treasurer | Tax withholding | 2,087 | $19.59 |
| 2026-09-01 | Hsieh Ming | Chief Executive Officer | Tax withholding | 4,392 | $19.59 |
| 2026-08-27 | Xie Jian | President and COO | Open market sale | 1,193 | $19.91 |
| 2026-08-27 | Gao Hanlin | Chief Scientific Officer | Open market sale | 939 | $19.91 |
| 2026-08-26 | Hsieh Ming | Chief Executive Officer | Tax withholding | 2,949 | $19.81 |
| 2026-08-26 | Kim Paul | CFO and Treasurer | Tax withholding | 1,168 | $19.81 |
| 2026-07-26 | Kim Paul | CFO and Treasurer | Tax withholding | 2,747 | $19.67 |
| 2026-07-26 | Xie Jian | President and COO | Tax withholding | 4,361 | $19.67 |
| 2026-07-26 | Gao Hanlin | Chief Scientific Officer | Tax withholding | 1,645 | $19.67 |
| 2026-06-02 | Xie Jian | President and COO | Open market sale | 2,146 | $17.89 |
| 2026-06-02 | Gao Hanlin | Chief Scientific Officer | Open market sale | 1,688 | $17.89 |
| 2026-06-01 | Kim Paul | CFO and Treasurer | Tax withholding | 2,087 | $18.09 |
| 2026-06-01 | Hsieh Ming | Chief Executive Officer | Tax withholding | 4,392 | $18.09 |
| 2026-05-27 | Xie Jian | President and COO | Open market sale | 1,201 | $17.60 |
| 2026-05-27 | Gao Hanlin | Chief Scientific Officer | Open market sale | 945 | $17.60 |
| 2026-05-26 | Kim Paul | CFO and Treasurer | Tax withholding | 1,168 | $17.67 |
| 2026-05-26 | Hsieh Ming | Chief Executive Officer | Tax withholding | 2,949 | $17.67 |
| 2026-05-14 | Nohaile Michael | Reporting person | Grant / award | 5,558 | $0.00 |
| 2026-05-14 | Dong Linda | Reporting person | Grant / award | 11,117 | $0.00 |
| 2026-05-14 | GROVES REGINA E | Reporting person | Grant / award | 11,117 | $0.00 |
| 2026-04-26 | Gao Hanlin | Chief Scientific Officer | Tax withholding | 1,645 | $16.31 |
| 2026-04-26 | Xie Jian | President and COO | Tax withholding | 4,361 | $16.31 |
| 2026-04-26 | Kim Paul | CFO and Treasurer | Tax withholding | 2,747 | $16.31 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:34 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-02 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-02 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-27 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-27 | View on SEC.gov → |
| 2026-07-30 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-30 | 8-K | 2026-07-30 | View on SEC.gov → |
| 2026-07-28 | 4 | 2026-07-26 | View on SEC.gov → |
| 2026-07-28 | 4 | 2026-07-26 | View on SEC.gov → |
Recent news
Headlines about FLGT (Fulgent Genetics, Inc.). Links open the publisher — we don’t host full articles.
-
How Long Can GeneDx Keep Burning Cash?
Yahoo · 2026-10-21 -
Fulgent Genetics, Inc. (FLGT) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-16 -
Fulgent Genetics Inc. R (7F0.MU) Q2 FY2026 earnings call transcript
Yahoo Finance · 2026-10-16 -
Fulgent Genetics Q3FY26 Results: Release date set for November 5
scanx.trade · 2026-10-15 -
Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Yahoo · 2026-10-15 -
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-08 -
Fulgent Genetics, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 2026-08-07 -
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets
Yahoo Finance · 2026-08-06
No headlines in this category right now — try “All”.